Marshall Wace’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$581M Sell
2,377,822
-1,290,441
-35% -$301M 0.58% 15
2025
Q4
$759M Buy
3,668,263
+84,101
+2% +$16.6M 0.69% 16
2025
Q3
$665M Buy
3,584,162
+2,000,609
+126% +$343M 0.67% 13
2025
Q2
$242M Buy
1,583,553
+670,669
+73% +$103M 0.27% 57
2025
Q1
$151M Sell
912,884
-3,144,826
-78% -$492M 0.19% 82
2024
Q4
$587M Sell
4,057,710
-1,213,797
-23% -$188M 0.71% 14
2024
Q3
$854M Buy
5,271,507
+1,386,545
+36% +$221M 1.04% 12
2024
Q2
$568M Buy
3,884,962
+3,244,862
+507% +$483M 0.76% 11
2024
Q1
$101M Buy
640,100
+538,800
+532% +$85.8M 0.15% 125
2023
Q4
$15.9M Buy
+101,300
New +$15.5M 0.03% 546
2023
Q3
Sell
-1,719,389
Closed -$284M 2451
2023
Q2
$285M Buy
1,719,389
+1,301,450
+311% +$210M 0.56% 20
2023
Q1
$64.8M Sell
417,939
-31,474
-7% -$5.08M 0.14% 158
2022
Q4
$79.4M Sell
449,413
-1,804,959
-80% -$312M 0.18% 120
2022
Q3
$368M Sell
2,254,372
-638,948
-22% -$108M 0.81% 9
2022
Q2
$514M Buy
2,893,320
+930,025
+47% +$166M 1.06% 6
2022
Q1
$348M Sell
1,963,295
-462,856
-19% -$78.8M 0.66% 15
2021
Q4
$415M Buy
2,426,151
+1,981,275
+445% +$324M 0.77% 12
2021
Q3
$71.8M Buy
444,876
+35,052
+9% +$5.98M 0.3% 50
2021
Q2
$67.5M Buy
409,824
+349,717
+582% +$57.9M 0.31% 57
2021
Q1
$9.88M Buy
+60,107
New +$9.73M 0.05% 457
2020
Q4
Sell
-16,295
Closed -$2.43M 2026
2020
Q3
$2.43M Sell
16,295
-178,924
-92% -$26.5M 0.02% 756
2020
Q2
$27.5M Sell
195,219
-551,428
-74% -$80.4M 0.19% 113
2020
Q1
$97.9M Buy
746,647
+191,984
+35% +$27.2M 0.98% 14
2019
Q4
$80.9M Sell
554,663
-134,322
-19% -$18.2M 0.56% 29
2019
Q3
$89.1M Buy
+688,985
New +$90.8M 0.7% 16
2019
Q2
Sell
-105,502
Closed -$14.7M 1589
2019
Q1
$14.7M Buy
105,502
+102,804
+3,810% +$13.8M 0.14% 178
2018
Q4
$348K Buy
+2,698
New +$376K ﹤0.01% 1198
2018
Q2
Sell
-20,602
Closed -$2.64M 765
2018
Q1
$2.64M Buy
20,602
+3,025
+17% +$409K 0.11% 158
2017
Q4
$2.46M Buy
17,577
+1,927
+12% +$268K 0.1% 171
2017
Q3
$2.04M Buy
15,650
+6,634
+74% +$879K 0.09% 159
2017
Q2
$1.19M Buy
+9,016
New +$1.15M 0.05% 182
2016
Q4
Sell
-493,260
Closed -$58.3M 1046
2016
Q3
$58.3M Buy
493,260
+417,816
+554% +$50.7M 0.41% 59
2016
Q2
$9.15M Buy
75,444
+44,578
+144% +$5.07M 0.08% 263
2016
Q1
$3.34M Sell
30,866
-104,080
-77% -$10.8M 0.03% 441
2015
Q4
$13.9M Sell
134,946
-674,487
-83% -$67.8M 0.13% 183
2015
Q3
$75.6M Buy
809,433
+738,623
+1,043% +$71.5M 0.93% 17
2015
Q2
$6.9M Buy
70,810
+49,550
+233% +$4.96M 0.09% 239
2015
Q1
$2.14M Sell
21,260
-112,218
-84% -$11.4M 0.03% 459
2014
Q4
$14M Sell
133,478
-127,130
-49% -$13.4M 0.18% 152
2014
Q3
$27.8M Buy
260,608
+144,789
+125% +$15M 0.4% 62
2014
Q2
$12.1M Buy
115,819
+52,481
+83% +$5.3M 0.18% 159
2014
Q1
$6.22M Buy
+63,338
New +$5.87M 0.11% 215

Other funds holding JNJ

Marshall Wace's JNJ Position: Q1 2026 in Review

Marshall Wace reduced its Johnson & Johnson (JNJ) stake by 35% in Q1 2026, selling an estimated $301M and leaving 2,377,822 shares worth $581M. The position accounts for 0.58% of the portfolio, ranked #15.

Marshall Wace first reported a position in JNJ in Q1 2014 and has held it in 42 quarters since. The position peaked at $854M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Marshall Wace held 2,377,822 shares of Johnson & Johnson worth $581M as of Q1 2026.
  • Marshall Wace sold 1,290,441 Johnson & Johnson shares in Q1 2026, an estimated $301M.
  • Johnson & Johnson made up 0.58% of Marshall Wace's portfolio in Q1 2026, its #15 holding.
  • Marshall Wace first reported a position in Johnson & Johnson in Q1 2014 and has held it in 42 quarters since.
  • Marshall Wace's Johnson & Johnson position peaked at $854M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.